References
Kälviäinen R, et al. Drugs 46: 1009–1024, 1993
Chadwick D. Epilepsia 35 (Suppl. 4): 3–10, 1994
Pellock JM. Epilepsia 35 (Suppl. 4): 11–18, 1994
French J. Ann Intern Med 120: 411–422, 1994
Lindhout D, Omtzigt JGC. Epilepsia 35 (Suppl. 4): 19–28, 1994
British National Formulary 26: 186–192, 1994
Davis R, et al. Drugs 47: 332–372, 1994
Pinder RM, et al. Drugs 13: 81–123, 1977
Erenberg G, et al. Am J Dis Child 136: 526–529, 1982
Villareal HJ, et al. Neurology 28: 886–891, 1978
Sato S, et al. Neurology 32: 157–163, 1982
Gilman JT, Duchowny M. CNS Drugs 1: 180–192, 1994
Covanis A, et al. Epilepsia 23: 693–720, 1982
Henriksen O, Johannessen SI. Acta Neurol Scand 65: 504–523, 1982
Behgi E, et al. Epilepsia 27: 323–330, 1986
Dreifuss FE, et al. Neurology 37: 379–385, 1987
Drugs Ther Perspect 2: 9–11, 20 Dec 1993
Rights and permissions
About this article
Cite this article
Valproic acid: useful first-line anticonvulsant but be aware of limitations. Drugs Ther. Perspect 4, 1–5 (1994). https://doi.org/10.2165/00042310-199404050-00001
Published:
Issue Date:
DOI: https://doi.org/10.2165/00042310-199404050-00001